Clinical Trial

Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 29, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
The study is to observe the therapeutic effects and long-term follow-up after ending anti-HBV therapy with nucleos(t)ide analogs in patients with chronic hepatitis b.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2016-08-24.
Trial Details
NCT Number NCT02883647
Lead Sponsor Third Affiliated Hospital, Sun Yat-Sen University
Conditions Chronic Hepatitis b
Enrollment 100 participants
Start Date 2014-01-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2024-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-29